12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks showed significant movement. Adial Pharmaceuticals, BioVie, Bone Biologics, Y-mAbs Therapeutics, Cardiff Oncology, and Biodesix experienced notable gains, with increases ranging from 17.53% to 76.0%. On the downside, Scilex Holding, Humacyte, Gritstone Bio, Precision BioSciences, Vivani Medical, and DermTech saw declines between 16.41% and 35.7%. The movements were largely attributed to recent Q4 earnings reports.
March 01, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adial Pharmaceuticals shares surged 76.0% to $3.59, with a market cap of $5.9 million.
The significant surge in ADIL's stock price could attract investor interest, potentially leading to short-term price volatility.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BioVie shares increased by 75.8% to $2.18, with a market cap of $86.9 million.
BioVie's substantial pre-market gain suggests positive investor sentiment, which could lead to short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Humacyte shares fell by 25.52% to $3.24, with a market cap of $335.5 million.
Humacyte's significant pre-market decline may reflect investor concerns, possibly leading to further short-term downside.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Scilex Holding shares declined by 35.7% to $1.46, with a market cap of $230.5 million.
The sharp decline in SCLX's stock price could indicate negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90